Monthly (qualifier value) – Talk Bio

Actionable Insights Powered by AI

Spotlight on LGBTQ+ Leaders Driving Change in Life Sciences

2 weeks ago talkbio0Tagged Biological Science Disciplines, Biopharma, Diversity, Fellows, GUTC, Health Workforce, Inclusion, Leadership, LGBTQ+ professionals, Monthly (qualifier value), philanthropy

LGBTQ+ professionals; life sciences; biopharma; leadership; Diversity and Inclusion; Health Workforce; GUTC Fellows; philanthropy; Pride Month

Eli Lilly makes Zepbound vials cheaper for self-paying patients

3 months ago talkbio0Tagged 10 mg, 7.5 mg, Dosage, Eli, Eli Lilly, Monthly (qualifier value), Prices, self-paying

self-paying, Eli, Eli Lilly, Prices, Monthly (qualifier value), Dosage, 7.5 mg, 10 mg

Metsera’s Long-Acting GLP-1 Drug Shows Promising 7.5% Weight Loss in 36 Days, Paving Way for Monthly Dosing

9 months ago talkbio0Tagged Clinical Trials, dosing, Glucagon-Like Peptide 1, long-acting drug, MET-097, Metsera, monthly, Monthly (qualifier value), Obesity

Metsera, GLP-1, obesity treatment, long-acting drug, weight loss, monthly dosing, MET-097, clinical trial results.

Eisai Seeks FDA Approval for Monthly IV Dosing of LEQEMBI for Alzheimer’s Disease Treatment

12 months ago talkbio0Tagged Alzheimer 's disease, Biogen, dosing, Eisai, Intravenous infusion procedures, lecanemab-irmb, Leqembi, Monthly (qualifier value), Subcutaneous Autoinjector, United States Food and Drug Administration

LEQEMBI, Eisai, FDA, Alzheimer’s disease, monthly IV dosing, subcutaneous autoinjector, lecanemab-irmb, Biogen

Novel Monthly Hemophilia A Treatment by Novos Poses Challenge to Roche’s Hemlibra

1 year ago talkbio0Tagged Hemlibra, Hemophilia A, Monthly (qualifier value), Novos, Performance, Roche (company)

Hemophilia A, Novos, Roche, Hemlibra, monthly treatment, performance, challenge.